Hartmann A - Search Results

1

Rapid and efficient screening for p53 gene mutations by dideoxy fingerprinting.

Blaszyk H, Hartmann A, Schroeder JJ, McGovern RM, Sommer SS, Kovach JS. Blaszyk H, et al. Among authors: hartmann a. Biotechniques. 1995 Feb;18(2):256-60. Biotechniques. 1995. PMID: 7727127

2

Hitherto unknown additive growth effects of fluorene and 2-acetylaminofluorene on bile duct epithelium and hepatocytes in rats.

Danz M, Hartmann A, Otto M, Blaszyk H. Danz M, et al. Among authors: hartmann a. Arch Toxicol Suppl. 1991;14:71-4. doi: 10.1007/978-3-642-74936-0_14. Arch Toxicol Suppl. 1991. PMID: 1805764 No abstract available.

3

Novel pattern of P53 mutation in breast cancers from Austrian women.

Hartmann A, Rosanelli G, Blaszyk H, Cunningham JM, McGovern RM, Schroeder JJ, Schaid DJ, Kovach JS, Sommer SS. Hartmann A, et al. J Clin Invest. 1995 Feb;95(2):686-9. doi: 10.1172/JCI117714. J Clin Invest. 1995. PMID: 7598762 Free PMC article.

4

p53 gene mutations inside and outside of exons 5-8: the patterns differ in breast and other cancers.

Hartmann A, Blaszyk H, McGovern RM, Schroeder JJ, Cunningham J, De Vries EM, Kovach JS, Sommer SS. Hartmann A, et al. Oncogene. 1995 Feb 16;10(4):681-8. Oncogene. 1995. PMID: 7862445

5

Novel pattern of p53 gene mutations in an American black cohort with high mortality from breast cancer.

Blaszyk H, Vaughn CB, Hartmann A, McGovern RM, Schroeder JJ, Cunningham J, Schaid D, Sommer SS, Kovach JS. Blaszyk H, et al. Among authors: hartmann a. Lancet. 1994 May 14;343(8907):1195-7. doi: 10.1016/s0140-6736(94)92403-1. Lancet. 1994. PMID: 7909871

6

A tandem CC-->TT transition in the p53 gene of a breast cancer.

Blaszyk H, Hartmann A, Wold LE, Schroeder JJ, McGovern RM, Sommer SS, Kovach JS. Blaszyk H, et al. Among authors: hartmann a. Hum Mutat. 1994;4(2):158-60. doi: 10.1002/humu.1380040212. Hum Mutat. 1994. PMID: 7981721 No abstract available.

7

p53 gene mutations in breast cancers in midwestern US women: null as well as missense-type mutations are associated with poor prognosis.

Saitoh S, Cunningham J, De Vries EM, McGovern RM, Schroeder JJ, Hartmann A, Blaszyk H, Wold LE, Schaid D, Sommer SS, et al. Saitoh S, et al. Among authors: hartmann a. Oncogene. 1994 Oct;9(10):2869-75. Oncogene. 1994. PMID: 8084591

8

Persistent proliferation of normal hepatocytes and promotion of preneoplastic development by N-nitrosodibenzylamine in rats.

Blaszyk H, Hartmann A, Danz M. Blaszyk H, et al. Among authors: hartmann a. J Cancer Res Clin Oncol. 1993;120(1-2):71-5. doi: 10.1007/BF01200727. J Cancer Res Clin Oncol. 1993. PMID: 8270612

9

Mutation detection by highly sensitive methods indicates that p53 gene mutations in breast cancer can have important prognostic value.

Kovach JS, Hartmann A, Blaszyk H, Cunningham J, Schaid D, Sommer SS. Kovach JS, et al. Among authors: hartmann a. Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1093-6. doi: 10.1073/pnas.93.3.1093. Proc Natl Acad Sci U S A. 1996. PMID: 8577720 Free PMC article.

10

High frequency of p53 gene mutations in primary breast cancers in Japanese women, a low-incidence population.

Hartmann A, Blaszyk H, Saitoh S, Tsushima K, Tamura Y, Cunningham JM, McGovern RM, Schroeder JJ, Sommer SS, Kovach JS. Hartmann A, et al. Br J Cancer. 1996 Apr;73(8):896-901. doi: 10.1038/bjc.1996.179. Br J Cancer. 1996. PMID: 8611423 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,464 results

Search Page

Filters